See more : NL Industries, Inc. (NL) Income Statement Analysis – Financial Results
Complete financial analysis of Towa Pharmaceutical Co., Ltd. (4553.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Towa Pharmaceutical Co., Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Jinlong Machinery & Electronic Co.,Ltd (300032.SZ) Income Statement Analysis – Financial Results
- Lake Shore Bancorp, Inc. (LSBK) Income Statement Analysis – Financial Results
- Environmental Solutions Worldwide, Inc. (ESWW) Income Statement Analysis – Financial Results
- American Overseas Group Limited (AOREF) Income Statement Analysis – Financial Results
- Innovative Payment Solutions, Inc. (IPSI) Income Statement Analysis – Financial Results
Towa Pharmaceutical Co., Ltd. (4553.T)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.towayakuhin.co.jp
About Towa Pharmaceutical Co., Ltd.
Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of diabetes, digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products. It had a portfolio of approximately 700 drug products. Towa Pharmaceutical Co., Ltd. was founded in 1951 and is headquartered in Osaka, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 227.93B | 208.86B | 165.62B | 154.90B | 110.38B | 105.10B | 93.43B | 84.95B | 82.12B | 71.47B | 61.35B | 55.24B | 48.72B | 46.15B | 39.04B | 35.97B | 31.50B | 29.24B | 24.19B | 24.76B |
| Cost of Revenue | 146.55B | 136.15B | 95.43B | 89.45B | 59.74B | 56.71B | 50.38B | 45.90B | 40.26B | 34.49B | 31.12B | 27.50B | 21.99B | 21.35B | 18.79B | 18.35B | 16.52B | 15.59B | 13.24B | 13.63B |
| Gross Profit | 81.38B | 72.71B | 70.19B | 65.45B | 50.65B | 48.40B | 43.05B | 39.05B | 41.85B | 36.98B | 30.23B | 27.74B | 26.73B | 24.80B | 20.25B | 17.62B | 14.98B | 13.65B | 10.96B | 11.14B |
| Gross Profit Ratio | 35.70% | 34.81% | 42.38% | 42.25% | 45.88% | 46.05% | 46.08% | 45.97% | 50.97% | 51.75% | 49.27% | 50.22% | 54.87% | 53.74% | 51.86% | 48.99% | 47.55% | 46.68% | 45.29% | 44.98% |
| Research & Development | 13.24B | 15.27B | 11.49B | 10.64B | 8.57B | 7.92B | 7.73B | 9.35B | 8.92B | 6.14B | 5.30B | 4.48B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 50.49B | 51.93B | 40.16B | 34.88B | 25.91B | 24.20B | 23.68B | 22.55B | 12.26B | 19.72B | 17.14B | 15.48B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 907.00M | 724.00M | 527.00M | 468.00M | 572.00M | 899.00M | 357.00M | 414.00M | 708.00M | 391.00M | 479.00M | 718.00M | -184.00M | -182.53M | 223.05M | -287.63M | 277.15M | 917.66M | 96.97M |
| Operating Expenses | 63.74B | 67.20B | 50.98B | 45.53B | 34.50B | 32.43B | 31.41B | 32.18B | 30.72B | 25.88B | 22.52B | 20.02B | 17.62B | 15.14B | 12.50B | 11.21B | 9.69B | 9.23B | 8.56B | 8.40B |
| Cost & Expenses | 210.29B | 203.34B | 146.41B | 134.98B | 94.24B | 89.14B | 81.79B | 78.08B | 70.98B | 60.36B | 53.64B | 47.52B | 39.61B | 36.49B | 31.30B | 29.56B | 26.21B | 24.82B | 21.80B | 22.03B |
| Interest Income | 97.00M | 17.00M | 8.00M | 23.00M | 81.00M | 48.00M | 58.00M | 29.00M | 103.00M | 110.00M | 46.00M | 49.00M | 25.00M | 23.00M | 28.49M | 39.54M | 171.78M | 180.99M | 99.55M | 122.70M |
| Interest Expense | 947.00M | 635.00M | 230.00M | 190.00M | 131.00M | 146.00M | 158.00M | 164.00M | 163.00M | 135.00M | 122.00M | 109.00M | 85.00M | 68.00M | 37.40M | 9.30M | 17.10M | 14.85M | 13.05M | 14.00M |
| Depreciation & Amortization | 17.89B | 19.41B | 10.95B | 10.43B | 8.29B | 8.34B | 8.17B | 7.98B | 7.33B | 5.72B | 5.41B | 4.91B | 2.64B | 1.87B | 1.79B | 1.85B | 1.47B | 1.30B | 950.90M | 739.63M |
| EBITDA | 35.54B | 24.92B | 29.49B | 30.35B | 24.46B | 24.62B | 19.82B | 15.12B | 18.46B | 16.84B | 13.20B | 14.33B | 12.46B | 11.38B | 9.16B | 8.11B | 6.07B | 5.70B | 3.26B | 3.86B |
| EBITDA Ratio | 15.59% | 12.94% | 19.14% | 20.45% | 23.29% | 24.63% | 22.88% | 18.59% | 23.99% | 25.44% | 22.55% | 23.97% | 25.67% | 24.64% | 24.10% | 23.82% | 21.19% | 21.38% | 18.26% | 15.04% |
| Operating Income | 17.65B | 5.51B | 19.21B | 19.92B | 16.14B | 15.97B | 11.64B | 6.87B | 11.13B | 11.11B | 7.71B | 7.72B | 9.11B | 9.66B | 7.74B | 6.41B | 5.29B | 4.42B | 2.40B | 2.73B |
| Operating Income Ratio | 7.74% | 2.64% | 11.60% | 12.86% | 14.62% | 15.19% | 12.46% | 8.09% | 13.56% | 15.54% | 12.56% | 13.98% | 18.70% | 20.92% | 19.84% | 17.82% | 16.78% | 15.11% | 9.91% | 11.04% |
| Total Other Income/Expenses | 6.81B | -909.00M | 3.04B | -1.20B | 4.57B | 2.92B | -1.81B | 368.00M | -1.23B | 4.10B | 996.00M | 1.59B | 624.00M | -220.00M | -412.00M | -164.04M | -710.08M | -53.11M | -119.84M | 348.44M |
| Income Before Tax | 24.46B | 4.61B | 22.25B | 18.73B | 20.71B | 18.89B | 9.83B | 7.24B | 9.90B | 15.21B | 8.70B | 9.31B | 9.73B | 9.44B | 7.33B | 6.24B | 4.58B | 4.36B | 2.28B | 3.08B |
| Income Before Tax Ratio | 10.73% | 2.20% | 13.43% | 12.09% | 18.76% | 17.97% | 10.52% | 8.52% | 12.06% | 21.28% | 14.18% | 16.85% | 19.98% | 20.45% | 18.78% | 17.36% | 14.53% | 14.93% | 9.41% | 12.45% |
| Income Tax Expense | 8.29B | 2.40B | 6.33B | 4.77B | 6.21B | 5.41B | 3.34B | 1.66B | 2.22B | 4.09B | 2.71B | 3.11B | 4.00B | 3.59B | 2.73B | 2.47B | 1.88B | 1.77B | 1.27B | 1.10B |
| Net Income | 16.17B | 2.20B | 15.91B | 13.96B | 14.50B | 13.48B | 6.50B | 5.58B | 7.68B | 11.12B | 5.99B | 6.20B | 5.74B | 5.85B | 4.60B | 3.78B | 2.69B | 2.60B | 1.01B | 1.99B |
| Net Income Ratio | 7.10% | 1.05% | 9.61% | 9.01% | 13.14% | 12.82% | 6.95% | 6.56% | 9.36% | 15.56% | 9.77% | 11.23% | 11.78% | 12.67% | 11.79% | 10.50% | 8.55% | 8.89% | 4.18% | 8.03% |
| EPS | 328.58 | 44.72 | 323.35 | 283.62 | 294.72 | 253.32 | 122.03 | 113.32 | 154.19 | 218.07 | 117.54 | 121.62 | 111.49 | 113.53 | 89.36 | 73.34 | 52.28 | 50.44 | 18.49 | 40.03 |
| EPS Diluted | 328.58 | 43.72 | 316.19 | 271.93 | 272.61 | 253.32 | 122.03 | 104.74 | 145.43 | 218.07 | 117.54 | 121.62 | 111.49 | 113.53 | 89.36 | 73.34 | 52.28 | 50.44 | 18.49 | 40.03 |
| Weighted Avg Shares Out | 49.22M | 49.22M | 49.22M | 49.21M | 49.21M | 53.19M | 53.22M | 49.21M | 49.84M | 50.99M | 50.99M | 50.99M | 51.46M | 51.50M | 51.50M | 51.50M | 51.50M | 51.50M | 50.67M | 47.91M |
| Weighted Avg Shares Out (Dil) | 49.22M | 50.34M | 50.32M | 51.28M | 53.17M | 53.19M | 53.22M | 53.23M | 52.84M | 50.99M | 50.99M | 50.99M | 51.46M | 51.50M | 51.50M | 51.50M | 51.50M | 51.50M | 50.67M | 47.91M |
Source: https://incomestatements.info
Category: Stock Reports